Centrica plc announces that it purchased on 17 April 2025 (through Merrill Lynch International) 100,000 Centrica plc ordinary shares of 6 14/81 pence each at a price of 149.51 pence per share. The purchased shares will be held as treasury shares. Such purchase was effected pursuant to the extension of the Company's 2024-25 buyback programme announced on 27 December 2024 and in accordance with the non-discretionary share repurchase agreement entered into with Merrill Lynch International as also announced on 27 December 2024, which agreement was subsequently amended as announced on 3 March 2025.
Since 3 March 2025, Centrica has purchased 44,251,864 ordinary shares at a cost (excluding dealing and associated costs) of £64,548,391.10.
Following the above purchase, Centrica plc holds 467,043,754 ordinary shares in treasury, and has 5,026,063,460 ordinary shares in issue (excluding treasury shares).
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), detailed information about the individual purchases made by Merrill Lynch International is set out below.
Transaction details: Centrica plc ordinary shares of 6 14/81 pence each
Issuer name:
Centrica plc
ISIN:
GB00B033F229
Intermediary name:
Merrill Lynch International
Intermediary Code:
MLILGB3LESF
Currency:
GBP
Aggregated information
Date of purchase:
17 April 2025
Number of ordinary shares purchased:
100,000
Highest price paid:
150.45p
Lowest price paid:
147.95p
Volume weighted average price paid per share:
149.51p
Disaggregated information
The table attached contains detailed information of the individual trades made byMerrill Lynch International, as part of the buyback programme.
Click on, or paste the following link into your web browser, to view the associated PDF document.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSFZGMDVNMGKZM
Compare our accounts
If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
